Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000950170-24-128609

CEO and President sold 2,505 shares at $0.54 ($1,355)

  • CEO and President acquired 7,812 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Shaff Eric D. · CEO and President

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-11-15 Exercise or conversion : show line 1 in the form 10b5-1 +7,812 172,894 D
2024-11-18 Sale : show line 2 in the form 10b5-1 −2,505 $0.54 $1,355 170,389 D
Open-market sales · 2,505 sh · avg $0.54 · $1,355

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-11-15 Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Units −7,812 70,313 D
Loading xslF345X05/ownership.xml…